SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
crescent
Lv2
200 积分
2023-08-01 加入
最近求助
最近应助
互助留言
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
10天前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
10天前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
12天前
已完结
The Efficacy of Pemigatinib in Advanced NSCLC with FGFR Aberration: case report
29天前
已完结
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma
1个月前
已完结
Somatic genomic and transcriptomic characterization of primary ovarian serous borderline tumors and low-grade serous carcinomas
1个月前
已完结
Perioperative targeted therapy for oncogene-driven NSCLC
1个月前
已完结
NTRK fusions and Trk proteins: what are they and how to test for them
3个月前
已完结
Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients
3个月前
已完结
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
3个月前
已完结
没有进行任何应助
感谢
8个月前
感谢
8个月前
感谢
8个月前
感谢
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论